OAT-GUT-BRAIN: Effects of Oats and Rice on Comprehensive Health of Metabolically Challenged Individuals

Overweight and Obesity Clinical Trial

Official title:

OAT-GUT-BRAIN: Comprehensive Health Effects of Long-term Consumption of Oats in Metabolically Challenged Volunteers - Gut-mediated Metabolomics and Vitality

Clinical Trial Details — Status: Active, not recruiting

Administrative data

• NCT number: NCT05526092
• Other study ID #: OGB
• Status: Active, not recruiting
• Phase: N/A
• Start date: September 12, 2022
• Est. completion date: December 2027

Study information

• Verified date: May 2024
• Source: University of Turku
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The overall objective of this research entity is to reveal the holistic health impact of oats in metabolically challenged individuals in a 6-week intervention, compared to that of rice. This is achieved by investigation of the plasma lipids, plasma antioxidant status, fecal microbiota and fecal bile acids. Additionally the effect of the 6-week diet on posptprandial glycemia and postprandial satiety and vitality are investigated.

Description:

Aims in this 6-week randomised, single-blinded clinical trial, including a postprandial study at the 6 week time point, with metabolically challenged volunteers on oat-rich low-gluten diet, are to:

1. Compare effect of oat and rice rich diets to blood lipid and glucose status, perceived gut well-being and diet quality.

2. Investigate changes in microbiota, SCFAs, plasma antioxidant status and inflammation markers resulting from consumption of oat or rice rich low gluten diets.

3. Examine the impact of the oat and rice rich gluten free diet on the change in metabolite profiles in blood.

4. Find out the long-term effects of oat and rice consumption on recovery and vitality by modulating the gut-brain axis and measured with neuropsychological testing and using tryptophan metabolites as markers.

5. Discover how the long-term consumption of oats and rice and their possible alterations in gut microbiota affect subsequent postprandial glycaemia and response of microbiota to the meal (as seen in plasma SCFAs).

Recruitment information / eligibility

• Status: Active, not recruiting
• Enrollment: 72
• Est. completion date: December 2027
• Est. primary completion date: December 2025
• Accepts healthy volunteers: No
• Gender: All
• Age group: 30 Years to 68 Years

Eligibility

Inclusion Criteria:

• Commits to follow low-gluten diet for 6 weeks

• 30 - 68 years of age

• BMI > 25 kg/m^2

• High cholesterol AND/OR Hypertension

Exclusion Criteria:

• Regular medication that can affect the gut

• Pregnancy or lactation

• Recent course of antibiotics (less than 3 months prior to the study)

Related Conditions & MeSH terms

• High Blood Pressure
• Hypercholesterolemia
• Hyperlipidemias
• Hypertension
• Overweight
• Overweight and Obesity

Intervention

Other:
• Dietary intervention
Changes in metabolism, microbiota, vitality and comprehensive health after 6 week consumption of oat / rice.

Locations

Country	Name	City	State
Finland	Institute of Public Health and Clinical Nutrition, University of Eastern Finland	Kuopio
Finland	Food Chemistry and Food Development, Department of Life Technologies, University of Turku	Turku

Sponsors (2)

Lead Sponsor	Collaborator
University of Turku	University of Eastern Finland

Country where clinical trial is conducted

Finland, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Changes from baseline in plasma short-chain fatty acids	Samples are taken 90 and 180 min after consuming the study meal, and at the fasting state, before and after the 6-week diet intervention to see the change between fasting state and postprandial states.	Week 0 and 6
Primary	Changes from baseline in plasma antioxidant capasity	Plasma samples are taken 180 min after consuming the study meal, and at the fasting state, before and after the 6-week diet intervention to see the change between fasting state and postprandial states. The antioxidant status of plasma will be analysed with commercial kits for 2,2'-azino-bis-3-ethylbenzthiazoline-6-sulfonic acid (ABTS) and Oxygen Radical Absorbance Capacity (ORAC) (Merck KGaA, Darmstadt, Germany) to measure antioxidant capacity of plasma.	Week 0 and 6
Primary	Changes in blood lipid	Postprandial plasma samples are taken at the fasting state and 15, 30, 45, 60, 90, 120 and 180 min after consuming the study meal before, and after the 6-week diet intervention to see blood lipid development curve in postprandial state.	Week 0 and 6
Primary	Changes in glucose status	Postprandial plasma samples are taken at the fasting state and 15, 30, 45, 60, 90, 120 and 180 min after consuming the study meal before, and after the 6-week diet intervention to see blood glucose development curve in postprandial state.	Week 0 and 6
Primary	Changes in inflammation markers	The inflammation markers in plasma are measured as a baseline before the study and after 6 week diet intervention. The markers will be analysed with cDNA multiplex immunoassay and qPCR giving semi-quantitative results on a log2 scale (Olink inflammation panel, Olink Proteomics, Uppsala, Sweden). The panel contains at least 92 different proteins that are related to inflammation.	Week 0 and 6
Primary	Changes in neuropsychological performance: cognitive load	Established and well-validated computerised neuropsychological tests to measure cognitive load will be conducted both at the beginning and at the end of the intervention in connection with postprandial test. Inquisit software (Millisecond Software, Seattle, Washington, USA; https://www.millisecond.com/download/library/) is used for the cognitive load (Serial Sevens Task) test.	Week 0 and 6
Primary	Changes in neuropsychological performance: reaction time and attention	Established and well-validated computerised neuropsychological tests to measure cognitive load will be conducted both at the beginning and at the end of the intervention in connection with postprandial test. Inquisit software (Millisecond Software, Seattle, Washington, USA; https://www.millisecond.com/download/library/) is used for the reaction time and attention (Color Word Stroop test) test.	Week 0 and 6
Primary	Changes in neuropsychological performance: response control	Established and well-validated computerised neuropsychological tests to measure cognitive load will be conducted both at the beginning and at the end of the intervention in connection with postprandial test. Inquisit software (Millisecond Software, Seattle, Washington, USA; https://www.millisecond.com/download/library/) is used for the response control (Cued Go/No-Go Task) test.	Week 0 and 6
Secondary	Changes in gastrointestinal symptoms	Gastrointestinal symptoms (self-reported) during a postprandial study as measured by a questionnaire. The questionnaire is divided into seven types of gastrointestinal discomfort, and also includes a possibility to describe a gastrointestinal discomfort outside these seven given alternatives. The severity of the symptoms is self-reported on a three-step scale (0 as mild or no symptoms, 1 as moderate symptoms, 2 as strong symptoms).	Weeks 0 and 6
Secondary	Changes in gut microbiota	Changes in gut microbiota during the dietary intervention as seen in sequencing the fecal samples from the study participants before and after the 6-week dietary intervention.	Week 0 and 6
Secondary	Changes in excreted bile acids	Changes in excreted bile acids during the dietary intervention analyses from the fecal samples of the study participants before and after the 6-week dietary intervention.	Week 0 and 6